MedPath

The Impact of Myo- inositol supplementation to gestational diabetes in overweight pregnant wome

Phase 3
Conditions
Diabetes mellitus arising in pregnancy.
Diabetes mellitus in pregnancy, unspecified
O24.9
Registration Number
IRCT20160208026446N2
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Conscious written consent
Pregnant women with singleton pregnancy
Age above 18 years old
Gestational age 14 weeks
Pr-pregnancy BMI>= 25 and less than 30 kg / m 2
Fasting glucose less than 92 mg / dL or Random glucose less than 200 mg / dL
No chronic diseases such as diabetes, high blood pressure and cardiovascular disease
Non-smoking and alcohol

Exclusion Criteria

The death experience of one of the first-degree relatives during pregnancy
Treatment with corticosteroids during pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath